Overview
Financials
Units: $M (per-share in $, ratios in %)Revenue & profit
Margins
Valuation
Multiples at each fiscal year end (annual) and current (TTM)Valuation history
Segments
Revenue breakdown (annual, $B). Segments depend on each year’s disclosure.By product
By region
Dividends & earnings
Annual dividend per share ($, split-adjusted)
EPS (diluted), last 16 quarters ($)
Company info
Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph. This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals. Founded in 2007, the firm's operations are headquartered in Southlake, Texas.